194 related articles for article (PubMed ID: 37061618)
21. High glucose promotes cell proliferation and enhances GDNF and RET expression in pancreatic cancer cells.
Liu H; Ma Q; Li J
Mol Cell Biochem; 2011 Jan; 347(1-2):95-101. PubMed ID: 20960036
[TBL] [Abstract][Full Text] [Related]
22. Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.
Perrinjaquet M; Vilar M; Ibáñez CF
J Biol Chem; 2010 Oct; 285(41):31867-75. PubMed ID: 20682772
[TBL] [Abstract][Full Text] [Related]
23. Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFR
Jmaeff S; Sidorova Y; Lippiatt H; Barcelona PF; Nedev H; Saragovi LM; Hancock MA; Saarma M; Saragovi HU
Mol Pharmacol; 2020 Jul; 98(1):1-12. PubMed ID: 32362584
[TBL] [Abstract][Full Text] [Related]
24. RET-mediated glial cell line-derived neurotrophic factor signaling inhibits mouse prostate development.
Park HJ; Bolton EC
Development; 2017 Jun; 144(12):2282-2293. PubMed ID: 28506996
[TBL] [Abstract][Full Text] [Related]
25. GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1.
Marks BA; Pipia IM; Mukai C; Horibata S; Rice EJ; Danko CG; Coonrod SA
BMC Cancer; 2023 Feb; 23(1):138. PubMed ID: 36765275
[TBL] [Abstract][Full Text] [Related]
26. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson's disease.
Mesa-Infante V; Afonso-Oramas D; Salas-Hernández J; Rodríguez-Núñez J; Barroso-Chinea P
Mol Cell Neurosci; 2022 Jan; 118():103684. PubMed ID: 34826608
[TBL] [Abstract][Full Text] [Related]
27. Unmasking a new prognostic marker and therapeutic target from the GDNF-RET/PIT1/p14ARF/p53 pathway in acromegaly.
Chenlo M; Rodriguez-Gomez IA; Serramito R; Garcia-Rendueles AR; Villar-Taibo R; Fernandez-Rodriguez E; Perez-Romero S; Suarez-Fariña M; Garcia-Allut A; Cabezas-Agricola JM; Rodriguez-Garcia J; Lear PV; Alvarez-San Martin RM; Alvarez-Escola C; Bernabeu I; Alvarez CV
EBioMedicine; 2019 May; 43():537-552. PubMed ID: 30975543
[TBL] [Abstract][Full Text] [Related]
28. RET in breast cancer: functional and therapeutic implications.
Morandi A; Plaza-Menacho I; Isacke CM
Trends Mol Med; 2011 Mar; 17(3):149-57. PubMed ID: 21251878
[TBL] [Abstract][Full Text] [Related]
29. Gas1 reduces Ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling.
López-Ramírez MA; Domínguez-Monzón G; Vergara P; Segovia J
Int J Dev Neurosci; 2008 Aug; 26(5):497-503. PubMed ID: 18394855
[TBL] [Abstract][Full Text] [Related]
30. Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival.
Coulpier M; Anders J; Ibáñez CF
J Biol Chem; 2002 Jan; 277(3):1991-9. PubMed ID: 11713247
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of microRNA-216a confers protection against yttrium aluminium garnet laser-induced retinal injury
Hu XB; Fu SH; Luo QI; He JZ; Qiu YF; Lai W; Zhong M
J Biosci; 2018 Dec; 43(5):985-1000. PubMed ID: 30541958
[TBL] [Abstract][Full Text] [Related]
32. Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.
Frisk T; Farnebo F; Zedenius J; Grimelius L; Höög A; Wallin G; Larsson C
Eur J Endocrinol; 2000 Jun; 142(6):643-9. PubMed ID: 10822229
[TBL] [Abstract][Full Text] [Related]
33. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells.
Trupp M; Scott R; Whittemore SR; Ibáñez CF
J Biol Chem; 1999 Jul; 274(30):20885-94. PubMed ID: 10409632
[TBL] [Abstract][Full Text] [Related]
34. Targeting RET-interleukin-6 crosstalk to impair metastatic dissemination in breast cancer.
Morandi A; Isacke CM
Breast Cancer Res; 2014 Jan; 16(1):301. PubMed ID: 24467886
[TBL] [Abstract][Full Text] [Related]
35. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor.
Hayashi H; Ichihara M; Iwashita T; Murakami H; Shimono Y; Kawai K; Kurokawa K; Murakumo Y; Imai T; Funahashi H; Nakao A; Takahashi M
Oncogene; 2000 Sep; 19(39):4469-75. PubMed ID: 11002419
[TBL] [Abstract][Full Text] [Related]
36. Expression of the RET proto-oncogene is regulated by TFAP2C in breast cancer independent of the estrogen receptor.
Spanheimer PM; Woodfield GW; Cyr AR; Kulak MV; White-Baer LS; Bair TB; Weigel RJ
Ann Surg Oncol; 2013 Jul; 20(7):2204-12. PubMed ID: 22878616
[TBL] [Abstract][Full Text] [Related]
37. GDNF/RET signaling in dopamine neurons in vivo.
Conway JA; Ince S; Black S; Kramer ER
Cell Tissue Res; 2020 Oct; 382(1):135-146. PubMed ID: 32870383
[TBL] [Abstract][Full Text] [Related]
38. Zebrafish GDNF and its co-receptor GFRα1 activate the human RET receptor and promote the survival of dopaminergic neurons in vitro.
Saarenpää T; Kogan K; Sidorova Y; Mahato AK; Tascón I; Kaljunen H; Yu L; Kallijärvi J; Jurvansuu J; Saarma M; Goldman A
PLoS One; 2017; 12(5):e0176166. PubMed ID: 28467503
[TBL] [Abstract][Full Text] [Related]
39. RET signaling in breast cancer therapeutic resistance and metastasis.
Pecar G; Liu S; Hooda J; Atkinson JM; Oesterreich S; Lee AV
Breast Cancer Res; 2023 Mar; 25(1):26. PubMed ID: 36918928
[TBL] [Abstract][Full Text] [Related]
40. c-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell lines.
Ohshima Y; Yajima I; Takeda K; Iida M; Kumasaka M; Matsumoto Y; Kato M
PLoS One; 2010 Apr; 5(4):e10279. PubMed ID: 20422010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
